Mulero Victoriano, Searle Susan, Blackwell Jenefer M, Brock Jeremy H
Department of Immunology and Bacteriology, Western Infirmary, University of Glasgow, Glasgow G11 6NT, Scotland, UK.
Biochem J. 2002 Apr 1;363(Pt 1):89-94. doi: 10.1042/0264-6021:3630089.
Solute carrier 11a1 (Slc11a1; formerly Nramp1; where Nramp stands for natural-resistance-associated macrophage protein) is a proton/bivalent cation antiporter that localizes to late endosomes/lysosomes and controls resistance to pathogens. In the present study the role of Slc11a1 in iron turnover is examined in macrophages transfected with Slc11a1(Gly169) (wild-type) or Slc11a1(Asp169) (mutant=functional null) alleles. Following direct acquisition of transferrin (Tf)-bound iron via the Tf receptor, iron uptake and release was equivalent in wild-type and mutant macrophages and was not influenced by interferon-gamma/lipopolysaccharide activation. Following phagocytosis of [(59)Fe]Tf-anti-Tf immune complexes, iron uptake was equivalent and up-regulated similarly with activation, but intracellular distribution was markedly different. In wild-type macrophages most iron was in the soluble (60%) rather than insoluble (12%) fraction, with 28% ferritin (Ft)-bound. With activation, the soluble component increased to 82% at the expense of Ft-bound iron (<5%). In mutant macrophages, 40-50% of iron was in insoluble form, 50-60% was soluble and <5% was Ft-bound. Western-blot analysis confirmed failure of mutant macrophages to degrade complexes 24 h after phagocytic uptake. Confocal microscopy showed that complexes were within lysosome-associated membrane protein 1-positive vesicles in wild-type and mutant macrophages at 30 min and 24 h, implying failure in the degradative process in mature phagosomes in mutant macrophages. NO-mediated iron release was 2.4-fold higher in activated wild-type macrophages compared with mutant macrophages. Overall, our data suggest that iron acquired by phagocytosis and degradation is retained within the phagosomal compartment in wild-type macrophages, and that NO triggers iron release by direct secretion of phagosomal contents rather than via the cytoplasm.
溶质载体11a1(Slc11a1;原名Nramp1;其中Nramp代表天然抗性相关巨噬细胞蛋白)是一种质子/二价阳离子反向转运蛋白,定位于晚期内体/溶酶体并控制对病原体的抗性。在本研究中,在转染了Slc11a1(Gly169)(野生型)或Slc11a1(Asp169)(突变体=功能缺失)等位基因的巨噬细胞中研究了Slc11a1在铁周转中的作用。通过转铁蛋白受体直接摄取与转铁蛋白(Tf)结合的铁后,野生型和突变型巨噬细胞中的铁摄取和释放相当,且不受干扰素-γ/脂多糖激活的影响。吞噬[(59)Fe]Tf-抗Tf免疫复合物后,铁摄取相当且随激活而类似地上调,但细胞内分布明显不同。在野生型巨噬细胞中,大多数铁存在于可溶性部分(60%)而非不溶性部分(12%),28%与铁蛋白(Ft)结合。激活后,可溶性成分增加到82%,以结合Ft的铁(<5%)为代价。在突变型巨噬细胞中,40-50%的铁为不溶性形式,50-60%为可溶性,<5%与Ft结合。蛋白质免疫印迹分析证实,吞噬摄取后24小时,突变型巨噬细胞无法降解复合物。共聚焦显微镜显示,在野生型和突变型巨噬细胞中,30分钟和24小时时复合物位于溶酶体相关膜蛋白1阳性囊泡内,这意味着突变型巨噬细胞成熟吞噬体中的降解过程失败。与突变型巨噬细胞相比,激活的野生型巨噬细胞中一氧化氮介导的铁释放高2.4倍。总体而言,我们的数据表明,野生型巨噬细胞中通过吞噬作用和降解获得的铁保留在吞噬体区室中,并且一氧化氮通过直接分泌吞噬体内容物而非通过细胞质触发铁释放。